DK1289364T3 - Stabil gapapentin som indeholder mere end 20 ppm chlorioner - Google Patents

Stabil gapapentin som indeholder mere end 20 ppm chlorioner

Info

Publication number
DK1289364T3
DK1289364T3 DK01946364T DK01946364T DK1289364T3 DK 1289364 T3 DK1289364 T3 DK 1289364T3 DK 01946364 T DK01946364 T DK 01946364T DK 01946364 T DK01946364 T DK 01946364T DK 1289364 T3 DK1289364 T3 DK 1289364T3
Authority
DK
Denmark
Prior art keywords
stable
gapapentin
chlorine ions
ppm chlorine
ppm
Prior art date
Application number
DK01946364T
Other languages
Danish (da)
English (en)
Inventor
Edi Schwartz
Claude Singer
Gideon Pilarski
Michael Pesachovich
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22788993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1289364(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of DK1289364T3 publication Critical patent/DK1289364T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
DK01946364T 2000-06-16 2001-06-15 Stabil gapapentin som indeholder mere end 20 ppm chlorioner DK1289364T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21196700P 2000-06-16 2000-06-16
PCT/US2001/019100 WO2001097612A1 (en) 2000-06-16 2001-06-15 Stable gabapentin containing more than 2o ppm of chlorine ion

Publications (1)

Publication Number Publication Date
DK1289364T3 true DK1289364T3 (da) 2004-04-13

Family

ID=22788993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01946364T DK1289364T3 (da) 2000-06-16 2001-06-15 Stabil gapapentin som indeholder mere end 20 ppm chlorioner

Country Status (12)

Country Link
US (1) US6531509B2 (es)
EP (1) EP1289364B1 (es)
AT (1) ATE255891T1 (es)
AU (1) AU2001268426A1 (es)
CA (1) CA2410867C (es)
DE (2) DE60101476T2 (es)
DK (1) DK1289364T3 (es)
ES (1) ES2193008T3 (es)
IL (1) IL153398A0 (es)
PT (1) PT1289364E (es)
TR (1) TR200302296T4 (es)
WO (1) WO2001097612A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001266992B8 (en) * 2000-06-16 2005-12-01 Teva Pharmaceutical Industries Ltd. Stable gabapentin having pH within a controlled range
US7056951B2 (en) * 2000-09-26 2006-06-06 Mutual Pharmaceutical Co., Inc. Stable solid dosage forms of amino acids and processes for producing same
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US20030119908A1 (en) * 2001-12-21 2003-06-26 Zambon Group S.P.A. Stable gabapentin compositions
AU2003301184A1 (en) * 2002-12-20 2004-07-22 Dynogen Pharmaceuticals Inc METHODS OF TREATING NON-PAINFUL BLADDER DISORDERS USING Alpha2Delta SUBUNIT CALCIUM CHANNEL MODULATORS
DE602004003172T2 (de) * 2003-03-21 2007-09-27 Dynogen Pharmaceuticals Inc., Waltham Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals
WO2005046566A2 (en) * 2003-08-04 2005-05-26 Sun Pharmaceutical Industries Limited Stable gabapentin containing composition
JP2007509971A (ja) * 2003-10-31 2007-04-19 アルザ・コーポレーシヨン メトホルミンの増加された吸収のための組成物及び投与形態物
US20050187295A1 (en) * 2004-02-19 2005-08-25 Surendra Kalyan Processes for the preparation of gabapentin
US20070092565A1 (en) * 2005-10-25 2007-04-26 Pharmascience Inc. Gastric retention drug delivery system
NL2000281C2 (nl) 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
CN101462975B (zh) * 2008-08-19 2012-07-25 宁波九胜创新医药科技有限公司 一种高纯度加巴喷丁的制备方法
CN116693410B (zh) * 2023-06-08 2024-06-07 浙江竹子制药有限公司 一种粒径可控的加巴喷丁制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460891C2 (de) 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2611690A1 (de) 1976-03-19 1977-09-22 Goedecke Ag Cyclische sulfonyloxyimide
US4960931A (en) 1988-05-02 1990-10-02 Warner-Lambert Company Gabapentin mohohydrate and a process for producing the same
US4894476A (en) 1988-05-02 1990-01-16 Warner-Lambert Company Gabapentin monohydrate and a process for producing the same
US5132451A (en) 1989-08-25 1992-07-21 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
US5319135A (en) 1989-08-25 1994-06-07 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
PH27359A (en) 1989-08-25 1993-06-21 Warner Lambert Co Process for cyclic amino acid anticonvulsant compounds
DE3928184A1 (de) 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
DE3928182A1 (de) 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von gabapentin
DE3928183A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Lactamfreie cyclische aminosaeuren
US5084479A (en) 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
US5025035A (en) 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
IL119890A (en) * 1996-12-24 2002-03-10 Teva Pharma Gabapentin form iii and preparation of gabapentin form ii
EP1077692B1 (en) * 1998-05-15 2004-07-28 Warner-Lambert Company LLC Amino acid stabilized gabapentin and pregabalin preparations and process for preparing the same
ID26395A (id) * 1998-05-15 2000-12-21 Warner Lambert Comapny Turunan asam gamma-aminobutirat yang mengandung komposisi padat dan proses pembuatannya
FR2781793B1 (fr) * 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
US6294198B1 (en) 1999-08-24 2001-09-25 Purepac Pharmaceutical Co. Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same
US7056951B2 (en) * 2000-09-26 2006-06-06 Mutual Pharmaceutical Co., Inc. Stable solid dosage forms of amino acids and processes for producing same

Also Published As

Publication number Publication date
WO2001097612A1 (en) 2001-12-27
DE60101476T2 (de) 2004-05-27
DE1289364T1 (de) 2003-09-18
ES2193008T1 (es) 2003-11-01
US6531509B2 (en) 2003-03-11
DE60101476D1 (de) 2004-01-22
US20020061931A1 (en) 2002-05-23
AU2001268426A1 (en) 2002-01-02
CA2410867C (en) 2003-12-09
EP1289364A4 (en) 2003-08-06
TR200302296T4 (tr) 2004-02-23
EP1289364A1 (en) 2003-03-12
CA2410867A1 (en) 2001-12-27
ES2193008T3 (es) 2004-07-01
EP1289364B1 (en) 2003-12-10
ATE255891T1 (de) 2003-12-15
IL153398A0 (en) 2003-07-06
PT1289364E (pt) 2004-04-30

Similar Documents

Publication Publication Date Title
DK1289364T3 (da) Stabil gapapentin som indeholder mere end 20 ppm chlorioner
HUP9900152A2 (hu) Alkoholalapú mikrobaellenes kozmetikai készítmény és alkalmazása
BR0211390A (pt) Tratamento de infecções da unha com no
MXPA01012336A (es) Gel de silicon que contiene acido salicilico.
TW200510375A (en) New compounds
MXPA04006542A (es) Composiciones bucales estables que contienen complejos de fosfopeptido de caseina y fluooruro.
MXPA04004109A (es) Composiciones cosmeticas anhidras que contienen compuestos de amonio cuaternario.
HRP20020198B1 (en) Moxifloxacin formulation containing common salt
RS20050066A (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
MXPA03009651A (es) COMPOSICIoN ACUOSA DE DOS PARTES PARA LA COLORACIoN OXIDATIVA DEL CABELLO.
GB0107311D0 (en) Corona ionisation source
MY133507A (en) New peroxy-carboxylic acid and aqueous compositions thereof
AR031782A1 (es) Dentifrico de astringencia reducida, que contiene zinc
ATE262277T1 (de) Wasser-dispergierbare agrochemische zusammensetzungen
AU2003294785A1 (en) Hair treatment compositions
FR2804319B1 (fr) Composition cosmetique amincissante comprenant en tant qu'agent actif un extrait de plante contenant de l'anp
ATE407656T1 (de) Haarbehandlungszusammensetzungen mit einem disaccharid; einer disäure und einer ammoniumionen-quelle
TW200517117A (en) Stabilized compositions containing an oxygen-labile active agent
CO5580729A2 (es) Composiciones nutricionales que comprenden cistationina
TW200507838A (en) Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
DK1307445T3 (da) Benzofuranderivater og deres anvendelse som antibakterielle midler
TR200401701T4 (tr) Zenginleştirilmiş besin ve terapötik etkinliğe sahip kreatin tuzu ve bunu içeren kompozisyonlar
ES2192136A1 (es) Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
MY152837A (en) Disinfectant and/or bactericidal aqueous compositions
ITMI20021246A1 (it) Composizioni minerali detossinanti a base di zeoliti ad elevata capacita' di scambio cationico